A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 2, 2006, Pages 281-287

  Giannini, E G ^a,b   Bilardi, C ^a   Dulbecco, P ^a   Mamone, M ^a   Santi, M L ^b   Testa, R ^a   Mansi, C ^a   Savarino, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Italian Association of the Sovereign Hospitaller Order of St John of Jerusalem   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; RABEPRAZOLE; TINIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOATING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; TIME SERIES ANALYSIS; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTITRICHOMONAL AGENTS; BENZIMIDAZOLES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; OMEPRAZOLE; PILOT PROJECTS; TIME FACTORS; TINIDAZOLE; TREATMENT OUTCOME;

EID: 33644595796     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02756.x     Document Type: Article

References (40)

1. Williams MP Pounder RE Helicobacter pylori: from the benign to the malignant Am J Gastroenterol 1999 94 Suppl. 11S 6S
2. Malfertheiner P Megraud F O'Morain C et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 2002 16 167 80
3. Howden CW Hunt RH Guidelines for the management of Helicobacter pylori infection. Ad hoc committee on practice parameters of the American College of Gastroenterology Am J Gastroenterol 1998 93 2330 8
4. Lam SK Talley NJ Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection J Gastroenterol Hepatol 1998 13 1 12
5. Gené E Calvet X Azagra R et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis Aliment Pharmacol Ther 2003 18 543 4
6. Gené E Calvet X Azagra R et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis Aliment Pharmacol Ther 2003 17 1137 43
7. Lee JM Breslin NP Hyde DK et al. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice Aliment Pharmacol Ther 1999 13 489 96
8. Della Monica P Lavagna A Masoero G et al. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy Aliment Pharmacol Ther 2002 16 1269 75
9. Altintas E Sezgin O Ulu O et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori World J Gastroenterol 2004 10 1656 8
10. Graham DY Lew GM Malaty HM et al. Factors influencing the eradication of Helicobacter pylori with triple therapy Gastroenterology 1992 102 493 6
11. Houben MH Van Der Beek D Hensen EF et al. A systematic review of Helicobacter pylori eradication therapy. The impact of antimicrobial resistance on eradication rates Aliment Pharmacol Ther 1999 13 1047 55
12. Gisbert JP Pajares JM Helicobacter pylori'rescue' therapy after failure of two eradication treatments Helicobacter 2005 10 363 72
13. Nista EC Candelli F Cremonini F et al. Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial Aliment Pharmacol Ther 2003 18 627 33
14. Zullo A Hassan C De Francesco V et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication Dig Liver Dis 2003 35 232 6
15. Bilardi C Dulbecco P Zentilin P et al. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial Clin Gastroenterol Hepatol 2004 2 997 1002
16. Gatta L Zullo A Perna F et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses Aliment Pharmacol Ther 2005 22 45 9
17. Hurenkamp GJB Van der Ende A Grundmeijer HGLM et al. Equally high efficacy of 4, 7, 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease Aliment Pharmacol Ther 2000 14 1065 70
18. Gambaro C Bilardi C Dulbecco P et al. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study Dig Liver Dis 2003 35 763 77
19. Logan RPH Dill S Bauer FE et al. The European 13C-urea breath test for the detection of Helicobacter pylori Eur J Gastroenterol Hepatol 1991 3 915 21
20. Savarino V Mela GS Zentilin P et al. Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test Am J Gastroenterol 1999 94 1203 8
21. Perri F Festa V Merla A et al. Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy' Aliment Pharmacol Ther 2003 18 815 20
22. Altamirano A Bondani A Adverse reactions to furazolidone and other drugs Scand J Gastroenterol 1989 24 Suppl. 169 70 80
23. Brogden RN Fitton A Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy Drugs 1994 47 983 1009
24. Watanabe Y Aoyama N Shirasaka D et al. Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy Dig Liver Dis 2003 35 711 5
25. Coehlo LGV Moretzsohn LD Vieira WLS et al. New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study Aliment Pharmacol Ther 2005 21 783 7
26. Gisbert JP Rescue therapy with levofloxacin after multiple H. pylori treatment failures Aliment Pharmacol Ther 2005 22 653 4
27. Matsuzaki K Koyama H Chiba A et al. In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates Jpn J Antibiot 1999 52 571 84
28. Rodvold KA Neuhauser M Pharmacokinetics and pharmacodynamics of fluoroquinolones Pharmacotherapy 2001 21 233S 52S
29. Gisbert JP Pajares JM Helicobacter pylori'rescue' regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 2002 16 1047 57
30. Zou J Yang ZX Quin ZM Laboratory and clinical study of levofloxacin against Helicobacter pylori Zhonghua Yi Xue Za Zhi 2003 83 1778 81
31. Branca G Spanu T Cammarota G et al. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy Int J Antimicrob Agents 2004 24 433 8
32. Stedman CA Barclay ML Review article: Comparison of the pharamcokinetics, acid suppression and efficacy of proton pump inhibitors Aliment Pharmacol Ther 2000 14 963 78
33. Horn J Review article: Relationship between the metabolism and efficacy of proton pump inhibitors - focus on rabeprazole Aliment Pharmacol Ther 2004 20 Suppl. 6 11 9
34. Hirai MH Azuma T Ite S et al. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori J Gastroenterol 1999 30 461 4
35. Tsutsui N Taneike I Ohara T et al. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori Antimicrob Agents Chemother 2000 44 3069 73
36. 13C-aminopyrine breath test Dig Dis Sci 2005 50 1207 13
37. Giannini EG Savarino V Testa R Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastro-oesophageal reflux disease Dig Dis Sci (in press) q2
38. Manes G Balzano A Tinidazole: from protozoa to Helicobacter pylori- the past, present and future of a nitroimidazole with peculiarities Expert Rev Anti Infect Ther 2004 2 695 705
39. Wang HH Chou JW Liao KF et al. One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy World J Gastroenterol 2005 11 1680 4
40. Zullo A Hassan C Lorenzetti R et al. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori Dig Liver Dis 2003 35 357 61